1. Home
  2. INDP vs HQI Comparison

INDP vs HQI Comparison

Compare INDP & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Logo HireQuest Inc. (DE)

HQI

HireQuest Inc. (DE)

HOLD

Current Price

$17.39

Market Cap

180.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INDP
HQI
Founded
2000
2002
Country
United States
United States
Employees
N/A
75000
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
171.9M
180.1M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
INDP
HQI
Price
$1.08
$17.39
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
103.7K
18.7K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
2.08%
EPS Growth
N/A
73.08
EPS
N/A
0.31
Revenue
N/A
$30,640,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.46
P/E Ratio
N/A
$57.13
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$7.38
52 Week High
$8.57
$19.01

Technical Indicators

Market Signals
Indicator
INDP
HQI
Relative Strength Index (RSI) 29.35 68.82
Support Level $0.92 $10.22
Resistance Level $2.95 N/A
Average True Range (ATR) 0.18 1.22
MACD -0.02 0.47
Stochastic Oscillator 5.83 72.03

Price Performance

Historical Comparison
INDP
HQI

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

About HQI HireQuest Inc. (DE)

HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.

Share on Social Networks: